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PERSONAL EXPERIENCE ON INVERTED PAPILLOMA SURGICAL TREATMENT 
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Francesco Dispenza², Riccardo Speciale¹ 
Introduction 
Inverted Papilloma (IP) of the nasal cavity and paranasal sinuses is a benign epithelial 
tumor of unknown etiology in which the epithelium invaginates towards the stroma [1, 
2]. IP was first described by Ward in 1854 and represents 0.5-4% of all sinonasal tumors 
[3], it arises from the mucosa of the lateral wall of the nasal cavity, almost always unilat-
erally. It affects three times more men than women and the peak incidence occurs be-
tween the 5th and 6th decade of life [4]. IP is characterized by a destructive pattern of 
local growth, tendency to recur and, occasionally, associated malignacy [5]. 
It is clinically significant because it is locally aggressive and its recurrence rates range 
from 5% to 30% [3,6-9]. Moreover, this tumor appears to undergo malignant transforma-
tion into squamous cell carcinoma in 5% to 15% cases [9]. 
 
Materials and Methods 
Data were obtained from the database of the Department of Otorhinolaryngology of 
AOUP “Paolo Giaccone” in Palermo from 2002 to 2012 and were used for a retrospective 
clinical study. The medical records of patients with a diagnosis of IP of nasal cavity or 
paranasal sinuses were collected for inclusion in the study. 
The patients were evaluated in terms of age, gender, site of presentation of the tumor, 
symptoms, radiologic studies, surgical treatment and evolution, clinical staging, compli-
cations of surgery, treatment of complications, recurrences, malignancy, and follow-up 
time. 
Investigation also included a full clinical and professional history, a complete general 
otorhinolaryngological physical exami-nation, and 4 mm flexible fiber nasofibrolaryngo-
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SUMMARY 
Inverted papilloma (IP), also known as papilloma Schneideriano or Ewing’s papilloma, is 
the most common benign epithelial tumor of the paranasal sinuses.  
It originates from the stroma sub-mucosa of the nasal cavity and paranasal sinuses, and 
as the name suggests, the papillomatous proliferation of squamous epithelium, instead 
of producing an exophytic growth, extends into the mucosa and as such is reversed. 
In this retrospective study we report our experience in the surgical treatment of inverted 
sinonasal papilloma. The aim of the study was to compare results obtained by endoscopic 
surgery vs results obtained through open surgery. 
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scopy to characterize the tumor. 
Clinical staging was based on Krouse’s 
staging system shown in Chart 1, which is 
widely used in studies of this disease, and 
was obtained through the use of imaging 
CT and/or RM [5,10]. To categorize treat-
ment, surgery was classified as endonasal 
endoscopic resection, external approach or 
combined approaches. 
The review took into account the medical 
records of 36 patients with a diagnosis of 
inverted papilloma confirmed by pathol-
ogy. No patient was excluded because of 
insufficient data. 
Recurrences were described as the reap-
pearance of tumors after being considered 
absent (by endoscopy and/or tomography) 
in the nasal fossae and paranasal sinuses.  
All patients were followed up in our clinic 
with regular endoscopic examinations for a 
period of 5 years: every three months for 
the first year, and then every four/six 
months for at least five years following 
treatment. After this we recommended an 
endoscopic examination once every year, 
because as we know, this illness is associ-
ated with an elevated percentage of recur-
rence, [11]. 
 
Results 
We examined 36 cases of IP. 80% (n=29) 
were male and the mean age at diagnosis 
was 58 years (± SD 6.7), ranging from 34 
to 83 years. 
33 were cases diagnosed in our hospital 
and 3 were patients with recurrences who 
were treated at other centres (all with ma-
lignant inverted papillomas). 
We divided our sample in the following way 
according to the Krouse classification: 14% 
of patients as T1, 50% of patients as T2, 
36% of patients as T3 (Figure 1). 
No patients had bilateral tumors, in 21 
patients the tumor was on the left side 
(58.3%), and on the right in 15 patients 
(41.6%). The tumor affected the lateral wall 
in 25 patients (69.4%), the maxillary sinus 
in 20 patients (55%), the ethmoid labyrinth 
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Table 1: The Krouse staging system (reproduced from: Krouse et al.,Laryngoscope.2000)  
Figure 1: Preoperative Staging of IP in 
our patients according to Krouse Stag-
ing System: no one was in T4 stage at 
the diagnosis time.  
Staging System for Inverted Papilloma 
  
T1 
Tumor totally confined to the nasal cavity, without extension into the si-
nuses. The tumor can be localized to one wall or region of the nasal cavity, or 
can be bulky and extensive within the nasal cavity, but must not extend into 
the sinuses or into any extranasal compartment.  
There must be no con-current malignancy 
T2 
Tumor involving the ostiomeatal complex, and ethmoid si-nuses, and/or the 
medial portion of the maxillary sinus, with or without involvement of the na-
sal cavity. There must be no concurrent malignancy 
T3 
Tumor involving the lateral, inferior, superior, anterior, or pos-terior walls of 
the maxillary sinus, the sphenoid sinus, and/or the frontal sinus, with or 
without involvement of the medial portion of the maxillary sinus, the ethmoid 
sinuses, or the nasalcavity. There must be no concurrent malignancy 
T4 
All tumors with any extranasal/extrasinus exension to invol-ve adjacent, con-
tiguous structures such as the orbit, the intracranial compartment, or the 
pterygomaxillary space. All tumors associated with malignancy 
in 18 patients (50%), the sphenoid sinus in 
12 patients (33%), and the frontal sinus in 
8 patients (22%).  
25 patients (69,4%) had an incision biopsy 
describing the inverted papilloma prior to 
surgery. The remaining patients were op-
erated for nasal polyps, with the diagnosis 
of inverted papilloma being an incidental 
finding among inflammatory polyps. All 
incision biopsy results were confirmed 
after removal of the surgical specimen [3]. 
We divided our patients into two groups: 
NR (n=27) patients free of recurrences, 
and R (n=9) patients with recurrence of 
pathology. Of 9 cases in the R group, three 
patients had already under-gone endona-
sal treatments at other clinics and had 
been referred to our hospital to evaluate 
the surgical treatment of tumor relapses, 6 
patients were found during our follow up.  
NR GROUP  
As shown in figure 2, endonasal endo-
scopic resection was performed in 24 
patients (89%); an external approach only 
was done in one patient (3,7%), and a com-
bined approach for tumor removal was 
performed in the other two patients (7,4%). 
There was no relation between tumor stag-
ing and the type of surgery, as described 
in recent literature [5]. 
GROUP R  
The first procedure performed  was en-
donasal endoscopic resection in 4 patients 
(44%); an external approach was used in 
four other patients (44%), and a combined 
approach for tumor removal was used  in 
only one patient (11%). The mean follow-up 
time was 42 months (ranging from 12 to 
84). The treatment of a recurrent tumor 
consisted of endonasal endoscopy in 7 pa-
tients (77.7%), two others were successfully 
treated to remove the entire tumor, 
through a combined approach. 
As shown in Table 2, ten patients were 
smokers and 13 were ex smokers, so in 
our cohort most patients had been ex-
posed to cigarette smoke. 12 were allergic 
to inhalant allergens and the same group 
had a history of nasal polyps.  
The occupations of the cohort varied 
widely, and included laborers, traders, 
pensioners, housewives and a truck driver. 
To conclude, we compared mean time of 
hospitalization in days to evaluate how 
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Figure 2: Different Surgical Treat-
ments employed for IP resection 
(External Approach vs Endoscopic 
Approach vs Combined one).  
Anamnestic data N° of  Patients (%) 
Smokers 10 (27.7) 
Former Smokers 13 (36.1) 
Allergies 12 (33.3) 
Nasal Polyps 12 (33.3) 
Job 
truck driver 1 (2.7); farmers 6 (16.6);  laborers 2 (5.5); 
workers 6 (16.6); janitors 2 (5.5); traders 4 (11.1); pension-
ers 8 (22.2); caregiver 1 (2.7); housewifes 4 (11.1);  
unemployed 2 (5.5) 
Table 2: History and anamnesis of study sample: percentage of smokers or former 
smokers is very high, as allergies and diagnosis of nasal polyps. Any correlation is noted 
these two different approaches 
(endoscopic Vs open) impacted upon hos-
pital costs. Our results showed that hospi-
talization length for open surgery was five 
days longer than post endoscopic treat-
ment hospitalization length (Figure 3). 
Finally, figure 4 shows the most frequent 
complaints related to nasal mass [12]. The 
most frequent symptoms were unilateral 
nasal block followed by rhinorrhea, head-
ache, epistaxis and anosmia. Anterior 
transparent serous rhinorrea, occasional 
monolateral epistaxis, frontal headache, 
anosmia and rarely otalgia omolateral were 
reported. None of the patients reported 
problems relating to  snoring or sense of 
smell. 
 
Discussion 
None of the medications that patients had 
tried had resulted in long term improve-
ments in symptoms. The physical examina-
tion began with an inspection of the exte-
rior of the nose: no deformities were 
found. 
The nasal cavities were investigated 
through antherior rhinoscopy and endo-
scopy by flexible instruments. Typically, 
we found a unilateral mass in the nostril 
originating from the middle meatus, its 
colour was from grey to pink, it had an 
uneven surface, a fleshy consistency, and 
sometimes bled on palpation, but was 
never painful. 
When such a lesion is associated with sec-
ondary inflammatory polyps, or develops 
within the context of a preexisting nasal 
polyposis, the characteristics listed above 
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Figure 3: Comparison of  hospitalization’s period (in days) after surgical removing of IP 
(External/Combined approach vs Endoscopic resection).  
Figure 4: Clinical Symptoms related to nasal mass.  
may be less obvious, and therefore the IP 
is macroscopically more difficult to distin-
guish. 
As with the diagnosis of all growths, uni-
lateral nasal endoscopic examinations 
must be followed by an CT and MRI as-
sessment. 
Of 36 cases, 19 underwent a CT scan and/
or MR in our hospital, the patients were 
able to show an paranasal sinus’ image 
done previously. The imaging findings that 
lead to a diagnosis of IP are a lesion with 
lobulated contours associated with bone 
remodeling; implanted in the nasal fossa 
or sinus. The inflammation, often secon-
dary to sinus disease, does not allow for 
the precise distinction of inflammatory 
lesions from tumor cells. Therefore, we 
resort to MRI, which shows the extent of 
the lesion and any structures involved. 
Moreover, it differentiates IP from sino-
nasal malignant tumors and inflammatory 
changes. 
The use of imaging techniques is not only 
important in understanding the nature of 
the injury and identifying the extension, 
but is also essential for preoperative stag-
ing. 
The frequency of carcinoma in patients 
with sinonasal IP is around 11%. In two 
thirds of cases, carcinoma occurs synchro-
nously with IP, but in some patients carci-
noma develops at a later time, after previ-
ous resection of IP metachronous carci-
noma. The associated malignancy is pre-
dominantly squamous cell carcinoma 
(SSC). In our group of patients any carci-
noma was identified through histological 
tests [13]. 
In the postoperative period we analyzed 
the incidence of pain, hemorrhage and 
time of hospitalization.  
Regardless of the success or the technique 
used, all surgery causes tissue damage 
and the release of mediators of inflamma-
tion and pain. One of the most frequently 
used methods of assessing pain in the 
clinical environment is the Visual Analog 
Scale (VAS) which we administered during 
the first 48 hours after surgery. The VAS is 
comprised of a 10 cm horizontal line, the 
ends of which define the minimum and 
maximum extremes of perceived pain. A 
mark on the line is made by the patient to 
indicate the intensity of pain and this is 
converted to a numerical value.  
Endoscopic approach was associated with 
mild pain in both groups. Moreover, the 
resection of papilloma in cases of recur-
rence is usually linked to moderate/severe 
pain regardless of the type of surgical 
resection.  
The most common postoperative complica-
tion in our patients was hemorrhage re-
solved by nasal packing in the first 12 
hours. There were no differences between 
our two groups. 
Endoscopic surgery alone is not suitable 
for all cases. In one series of 104 cases 
when used in isolation the rate of recur-
rence was 22.4% which dropped to 16.2% 
when combined with open procedures for 
more extensive disease [14]. It has been 
proposed that endoscopic surgery alone is 
suitable for those lesions confined to the 
lateral nasal wall with or without extension 
into the ethmoid, maxillary and sphenoid 
sinuses [15]. 
Given that relapse can occur even several 
years after the primary tumours, we recom-
mend long-term monitoring of these pa-
tients [16]. 
With the support of the data in the litera-
ture and based on our experience, we 
believe that endoscopic treatment is the 
best treatment option as it is associated 
with lower morbidity. 
With regards to rhinosinusal anatomy and 
physiology, endoscopic sugery has the 
following advantages: the absence of ex-
ternal scars, reduced postoperative pain, 
lower postoperative length of stay (average 
3 days), as well as a lower percentage 
relapse (33% vs. 45%) compared to open 
surgery, observed in our study. 
However, given the retrospective nature of 
our study, the limited number of both 
relapse patients and those who were first 
treated at our unit, we cannot confirm with 
certainty that the lower occurrence of re-
lapse is related exclusively to endoscopic 
treatment of IP. However, we are fully con-
vinced that endoscopic surgery is the gold 
standard for the treatment of this injury, 
with the exception of cases with massive 
invasion of the frontal sinus, into the na-
sofrontal duct, orbit and frontal sinus 
which may be better treated with a com-
bined procedure [15]. 
 
Conclusion 
A key element to consider in the manage-
ment of patients with IP is a careful follow-
up for at least five years. As extensively 
documented in the literature, the nose-
sinus inverted papilloma is characterized 
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by the tendency to recur and therefore,  
long-term follow-up is essential for early 
detection of any recurrence. In the last ten 
years, the greater accuracy of new angled 
endoscopes, which allow for  "around the 
corner" vision and for optimal definition of 
the boundaries of the tumor to normal 
tissue, together with "training" of the en-
doscopic surgeon, which has gradually 
improved their performance, have enabled 
us to achieve great success with radical 
surgical treatment of the lesion.  
A detailed knowledge of the complex anat-
omy of the rhino-sinus area is key as re-
gards safety in endoscopic surgery of the 
paranasal sinuses. The study of the ana-
tomical details with intranasal angled 
lenses, if implemented with the three-
dimensional endoscopic vision, allows for 
a careful analysis of the nose/sinus area, 
which is characterized by a high anatomi-
cal variability. Another tool which is of 
great help in the study of anatomy is the 
high-resolution CT, which thanks to tech-
nological upgrading is now able to provide 
a precise reconstruction in three planes of 
space. 
Endoscopic surgery training therefore is 
essential as it requires the surgeon to use 
and compare endoscopic, macroscopic and 
radiological (CT) anatomical images .  
In conclusion, in recent years thanks to the 
technological development of endoscopic 
equipment and an improvement in image 
quality, we have witnessed a broadening of 
indications for endoscopic surgical ap-
proaches, overcoming previously perceived 
anatomical limitations.  
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